SINGLE ANTIPLATELET THERAPY

Clinical trials for SINGLE ANTIPLATELET THERAPY explained in plain language.

Never miss a new study

Get alerted when new SINGLE ANTIPLATELET THERAPY trials appear

Sign up with your email to follow new studies for SINGLE ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Heart treatment trial aims to reduce bleeding risk in elderly patients

Disease control Recruiting now

This international study is testing whether using just one blood-thinning medication is as safe and effective as using two after a specific type of heart artery procedure. It focuses on patients aged 75 and older or those at high risk for bleeding. The goal is to find the best ba…

Matched conditions: SINGLE ANTIPLATELET THERAPY

Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

SINGLE ANTIPLATELET THERAPY

Get alerted when new SINGLE ANTIPLATELET THERAPY trials appear

Heart treatment trial aims to reduce bleeding risk in elderly patients